Galenika is a renowned pharmaceutical manufacturer based in Serbia, recognized for its long-standing tradition of excellence, innovation, and commitment to improving global health. Established in 1945, the company has evolved into one of the most trusted pharmaceutical producers in Southeast Europe, combining decades of expertise with cutting-edge technology to deliver high-quality medicines that are both effective and affordable.

With modern pharmaceutical manufacturing facilities in Belgrade, Galenika operates according to Good Manufacturing Practice (GMP) standards, ensuring that every product meets the highest levels of safety, quality, and regulatory compliance. The company’s state-of-the-art production lines enable the manufacturing of various dosage forms, including tablets, capsules, liquids, creams, and injectables, catering to a wide range of therapeutic areas.

Galenika’s main focus lies in generic medicines, offering bioequivalent alternatives to branded drugs that make healthcare more accessible and cost-effective. Its product portfolio covers key treatment categories such as cardiovascular health, central nervous system disorders, gastrointestinal diseases, pain management, and respiratory care. By providing affordable generic pharmaceuticals, Galenika helps healthcare systems reduce costs while maintaining the highest therapeutic standards.

Beyond generics, Galenika has a strong presence in over-the-counter (OTC) medicines and consumer healthcare products. Its self-care portfolio includes vitamins, nutritional supplements, dermatological products, and wellness solutions designed to support everyday health and preventive care. This combination of prescription drugs and consumer health products positions Galenika as a comprehensive healthcare provider that meets the needs of both patients and professionals.

A core strength of Galenika is its ability to serve as a trusted partner for contract manufacturing and private-label production. With extensive expertise in formulation, packaging, and regulatory compliance, the company collaborates with international partners seeking reliable pharmaceutical manufacturing in Europe. Its flexible and scalable operations make Galenika an ideal choice for companies looking to outsource production without compromising on quality.

Galenika’s long-term strategy is built around innovation, sustainability, and growth. The company continuously invests in research and development, modernizes its production technology, and promotes environmentally responsible manufacturing practices. Its commitment to ethical operations and sustainable business growth reflects its broader mission: to contribute to a healthier, more equitable world through science and innovation.

With a strong domestic presence and expanding export markets across Europe, the Middle East, and Africa, Galenika is establishing itself as a global name in pharmaceutical manufacturing. Its dedication to quality, affordability, and accessibility has earned it the trust of millions of patients and healthcare professionals worldwide.